Alberto Ivan Salido-Guadarrama

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
At present, prostate-specific antigen (PSA) is used as a clinical biomarker for prostate cancer (PCa) diagnosis; however, a large number of patients with benign prostate hyperplasia (BPH) with PSA(More)
  • 1